In a murine model of graft-versus-host disease (GVHD), an infusion of ICAM-1+ BM-MSCs reduced the expression of inflammatory cytokines and the percentage of Th1 lymphocytes. The gene discussed is ICAM1; the disease is graft versus host disease.